Your browser doesn't support javascript.
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.
Zhang, B Y; Chen, M; Chen, X C; Cao, K; You, Y; Qian, Y J; Yu, W K.
  • Zhang BY; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • Chen M; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • Chen XC; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • Cao K; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • You Y; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • Qian YJ; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
  • Yu WK; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
Br J Surg ; 108(1): e9-e11, 2021 Jan 27.
Article in English | MEDLINE | ID: covidwho-1901118
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Berberine / Inflammation Mediators / COVID-19 / COVID-19 Drug Treatment / Anti-Inflammatory Agents Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Br J Surg Year: 2021 Document Type: Article Affiliation country: Bjs

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Berberine / Inflammation Mediators / COVID-19 / COVID-19 Drug Treatment / Anti-Inflammatory Agents Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Br J Surg Year: 2021 Document Type: Article Affiliation country: Bjs